ProductsPricingFree Market DashboardMarket News FeedScannerChartsHeatmapMarket SectorsTrack RecordMAD AcademyMCP Connector

Jazz Pharmaceuticals, Inc. (JAZZ)

Nasdaq · Common stock · Pharmaceutical Preparations

$213.31-0.45 (-0.21%)

As of Oct 21, 2:18 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.

Follow JAZZ in real time

Real-time quotes, Pro Charting, the scanner and the alert feed on JAZZ and every other US listing.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Or open the free JAZZ chart →

JAZZ at a glance

Key statistics

$13.88B

Market capitalization

Previous close
$213.76
Open
$212.74
Day range
$211.53 – $214.72
Volume
412.6K
Average volume (30 sessions)
800.9K
Shares outstanding
64.91M
Price / earnings
14.8
Earnings per share
$14.49
Price / book
2.9
Price / sales
3.0
Beta (1 year, vs SPY)
0.54

Where the price sits in its year

52-week range

61% of the range

Below the 52-week high
-19.9%
Above the 52-week low
+65.6%

Completed sessions through Oct 20, 2026

Technical snapshot

Below its 50-day and 200-day averages

20-day average
$225.15-5.1%
50-day average
$238.12-10.2%
200-day average
$214.87-0.5%
RSI (14)34.9

Between the conventional 30 and 70 bands.

+1.6%

1 week

-11.5%

1 month

-14.6%

3 months

+25.7%

Year to date

+57.1%

1 year

Price change over each window, from completed sessions. Past performance does not indicate future results.

Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.

The member platform, in real time

What members do with JAZZ

Every plan

JAZZ on Pro Charting

Every intraday interval in real time, the drawing kit and the full set of technical studies on JAZZ.

See the plans →

Every plan

Screen names like JAZZ

The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.

See the plans →

Analysis Tools Only

Set a price line on JAZZ

Put JAZZ on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.

See the plans →

Stock Alerts + Tools

Open alerts on JAZZ

See whether there is an open premium alert on JAZZ, with its entry, stop and exit, each one reviewed by an analyst before it is sent.

See the plans →

From the public news wire

JAZZ headlines

Market news →

SEC Form 4, most recent first

Insider filings

How to read these →

  • GALA RENEE D

    −2.0K

    President & CEO, Director · Open-market sale

    $472.80K · Oct 6, 2026

  • COZADD BRUCE C

    −6.0K

    Director · Open-market sale

    $1.38M · Oct 1, 2026

  • Patil Neena M

    −1.2K

    EVP & Chief Legal Officer · Open-market sale

    $289.13K · Sep 10, 2026

  • Henderson Mary Elizabeth

    −1.4K

    SVP, Technical Operations · Shares withheld for tax

    $343.16K · Sep 8, 2026

  • GALA RENEE D

    −2.0K

    President & CEO · Open-market sale

    $486.06K · Sep 8, 2026

  • GALA RENEE D

    −2.0K

    President & CEO · Shares withheld for tax

    $485.48K · Sep 8, 2026

  • Henderson Mary Elizabeth

    −15

    SVP, Technical Operations · Shares withheld for tax

    $3.62K · Sep 8, 2026

  • McSharry Heather Ann

    −1.8K

    Director · Shares withheld for tax

    $444.16K · Aug 31, 2026

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

Exchange
Nasdaq
Security
Common stock
Industry
Pharmaceutical Preparations
Headquarters
Dublin
Employees
2,890
Listed since
Jun 1, 2007
Website
jazzpharmaceuticals.com
Educational content only. MadStockAlerts provides market commentary, research, and educational content. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security. Trading and investing involve substantial risk, including loss of capital. See the Risk Disclosure and Customer Agreement.

Pick the desk that fits how you trade

Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.

Start 5 days free

Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.

Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.